Skip to main content
Equibles

Madison El-Sadi

Analyst

Brie Riley

Equibles does not estimate personal net worth.

About Madison El-Sadi

Madison El-Sadi is recorded as Analyst at Brie Riley. Madison El-Sadi has spoken on 1 earnings call across 1 company, most recently for Eton Pharmaceuticals, Inc. on November 5, 2026. The companies whose calls Madison El-Sadi spoke on are classified in the Healthcare sector.

Madison El-Sadi on recent calls

“Now that you've passed the $200 million exit 27 run rate goal that you had previously set, you had also set a $500 million 2030 target. I guess how should we think about the target now that replaces those?”
Analyst — Brie Riley, Eton Pharmaceuticals Q3 2026 Earnings Call ·

Affiliation history

  • Brie Riley

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity